Advaxis, Inc.

NASDAQ:ADXS  
0.38
-0.02 (-4.21%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Advaxis, Inc. Stock, NASDAQ:ADXS

9 Deer Park Drive, Suite K-1, Princeton, New Jersey 08852
United States of America
Phone: +1.609.452.9813
Number of Employees: 18

Description

Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ.